(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 17.93%85.87B | 17.19%56.37B | 8.09%24.29B | -6.94%101.7B | -9.79%72.82B | -12.85%48.1B | -24.20%22.47B | -12.11%109.29B | -17.48%80.72B | -10.51%55.19B |
Operating income | 17.93%85.87B | 17.19%56.37B | 8.09%24.29B | -6.94%101.7B | -9.79%72.82B | -12.85%48.1B | -24.20%22.47B | -12.11%109.29B | -17.48%80.72B | -10.51%55.19B |
Operating expenses | -19.39%-81.69B | -18.59%-53.46B | -10.06%-23.04B | 7.08%-95.89B | 9.52%-68.42B | 12.95%-45.08B | 24.97%-20.93B | 13.08%-103.2B | 19.27%-75.62B | 12.00%-51.79B |
Gross profit | -4.74%4.19B | -3.68%2.9B | -18.72%1.25B | -4.64%5.81B | -13.83%4.4B | -11.34%3.02B | -11.83%1.54B | 8.32%6.1B | 23.00%5.1B | 20.49%3.4B |
Selling expenses | 6.12%-719.33M | 6.05%-486.35M | -4.51%-250.95M | -0.86%-1.08B | 3.91%-766.25M | 2.86%-517.65M | -1.00%-240.12M | -9.58%-1.07B | -14.85%-797.4M | -14.53%-532.87M |
Administrative expenses | 3.61%-2.3B | 5.90%-1.5B | 5.14%-693.84M | 0.43%-3.38B | 2.74%-2.38B | -0.48%-1.6B | 0.48%-731.41M | -8.56%-3.39B | -15.13%-2.45B | -13.52%-1.59B |
Research and development expenses | 12.71%-124.34M | -198.70%-77.29M | 8.95%-26.49M | -18.89%-233.19M | -34.05%-142.45M | 47.10%-25.88M | -15.93%-29.1M | -14.30%-196.14M | -9.97%-106.26M | 25.90%-48.92M |
Profit from asset sales | -71.99%41.36M | -80.54%12.07M | -258.56%-851.87K | -4.93%186.26M | 1,529.95%147.64M | 847.37%61.99M | -65.85%537.24K | 67.46%195.91M | -91.56%9.06M | -85.47%6.54M |
Revaluation surplus | 177.02%38.34M | 53.24%-12.76M | -81.27%-14.95M | 354.32%266.88M | 46.78%-49.77M | 64.93%-27.29M | 86.24%-8.25M | -201.71%-104.94M | -209.39%-93.53M | -146.28%-77.82M |
-Changes in the fair value of other assets | 177.02%38.34M | 53.24%-12.76M | -81.27%-14.95M | 354.32%266.88M | 46.78%-49.77M | 64.93%-27.29M | 86.24%-8.25M | -201.71%-104.94M | -209.39%-93.53M | -146.28%-77.82M |
Impairment and provision | -32.84%-113.44M | -116.88%-100.11M | -31.24%-50.59M | -144.36%-351.89M | 1.18%-85.4M | 18.76%-46.16M | -170.53%-38.55M | 58.81%-144M | -402.03%-86.41M | -1,865.36%-56.82M |
-Other impairment is provision | -32.84%-113.44M | -116.88%-100.11M | -31.24%-50.59M | -144.36%-351.89M | 1.18%-85.4M | 18.76%-46.16M | -170.53%-38.55M | 58.81%-144M | -402.03%-86.41M | -1,865.36%-56.82M |
Special items of operating profit | -9.03%3.05B | -7.14%1.98B | 1.24%955.9M | 17.49%4.78B | 12.25%3.35B | 6.94%2.14B | 43.34%944.17M | -7.53%4.07B | 1.53%2.98B | 6.22%2B |
Adjustment items of operating profit | ---- | ---- | ---- | ---- | --0.01 | ---- | ---- | ---- | ---- | ---- |
Operating profit | -10.40%3.83B | -10.74%2.57B | -19.86%1.1B | 10.29%5.73B | -2.24%4.28B | -3.05%2.88B | 2.45%1.37B | -1.32%5.2B | 4.48%4.37B | 3.21%2.97B |
Financing cost | -31.30%-249.25M | -215.93%-126.61M | 46.91%-84.59M | -613.77%-259.08M | -232.39%-189.83M | -184.24%-40.08M | -9.12%-159.33M | 112.62%50.43M | 155.65%143.38M | 126.97%47.57M |
Special items of earning before tax | 118.17%61.78M | 231.18%55.11M | -81.76%2.61M | 928.87%36.8M | 142.67%28.32M | 213.79%16.64M | 5.70%14.31M | 96.71%-4.44M | 109.66%11.67M | -651.21%-14.62M |
Earning before tax | -11.44%3.64B | -12.51%2.5B | -17.07%1.02B | 5.09%5.51B | -9.15%4.11B | -4.89%2.85B | 1.68%1.23B | 10.80%5.24B | 18.93%4.53B | 11.06%3B |
Tax | 26.67%-605.65M | 23.43%-413.59M | 23.00%-175.63M | -9.30%-1.06B | -9.17%-825.92M | 2.37%-540.14M | -9.08%-228.08M | -21.01%-967.54M | -31.52%-756.56M | -22.85%-553.25M |
After-tax profit from continuing operations | -7.62%3.04B | -9.97%2.08B | -15.72%842.3M | 4.13%4.45B | -12.83%3.29B | -5.47%2.31B | 0.13%999.42M | 8.72%4.28B | 16.69%3.77B | 8.71%2.45B |
Earning after tax | -7.62%3.04B | -9.97%2.08B | -15.72%842.3M | 4.13%4.45B | -12.83%3.29B | -5.47%2.31B | 0.13%999.42M | 8.72%4.28B | 16.69%3.77B | 8.71%2.45B |
Minority profit | 58.14%212.3M | 7.88%139.1M | -8.48%39.56M | 17.33%230.85M | -31.10%134.25M | 7.10%128.94M | 178.34%43.23M | -10.29%196.75M | 27.44%194.84M | 33.83%120.39M |
Profit attributable to shareholders | -10.41%2.83B | -11.02%1.95B | -16.05%802.73M | 3.50%4.22B | -11.83%3.15B | -6.11%2.19B | -2.69%956.19M | 9.85%4.08B | 16.16%3.58B | 7.66%2.33B |
Basic earnings per share | -9.53%0.3891 | -11.17%0.268 | -15.38%0.11 | 5.01%0.5827 | -11.01%0.4301 | -2.68%0.3017 | 0.00%0.13 | 10.98%0.5549 | 15.07%0.4833 | 6.90%0.31 |
Diluted earnings per share | -9.72%0.3883 | -11.37%0.2674 | -15.38%0.11 | 4.92%0.5822 | -11.01%0.4301 | -2.68%0.3017 | 0.00%0.13 | 10.98%0.5549 | 15.07%0.4833 | 6.90%0.31 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
Auditor | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data